During the past decade, Taranaki Base Hospital conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 2 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Taranaki Base Hospital" #1 sponsor was "Pfizer" with 2 trials, followed by "University of Auckland, New Zealand" with 2 trials sponsored, "American Regent, Inc." with 1 trials sponsored, "ChemoCentryx" with 1 trials sponsored and "Hospital do Coracao" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Taranaki Base Hospital" #1 collaborator was "Australia and New Zealand Dialysis and Transplant Registry" with 1 trials as a collaborator, "Australian and New Zealand Intensive Care Research Centre" with 1 trials as a collaborator, "Berry Consultants" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator and "Duke Clinical Research Institute" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Taranaki Base Hospital" are "Cardiovascular Disease" (2 trials), "Acute ST Segment Elevation Myocardial Infarction" (1 trials), "Anemia" (1 trials), "Antimicrobial" (1 trials) and "Bacteremia" (1 trials). Many other conditions were trialed in "Taranaki Base Hospital" in a lesser frequency.

Most popular intervention types in "Taranaki Base Hospital" are "Drug" (9 trials), "Other" (3 trials), "Biological" (2 trials), "Behavioral" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "bococizumab (PF-04950615)" (2 trials), "14 days of adequate antibiotic treatment." (1 trials), "7 days of adequate antibiotic treatment" (1 trials) and "ARB + DMX-200" (1 trials). Other intervention names were less common.

The vast majority of trials in "Taranaki Base Hospital" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Taranaki Base Hospital". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Taranaki Base Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Taranaki Base Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".